Ophthotech Corporation (NASDAQ:OPHT)
Ophthotech Corporation is a biopharmaceutical company. It is focused on developing and commercializing novel therapies for the treatment of diseases of the eye. The Company is developing Fovista and ARC1905, which are under clinical trials, for the treatment of wet AMD. Ophthotech Corporation is headquartered in New York.
Ophthotech Corporation (NASDAQ:OPHT)’s Financial Overview
Ophthotech Corporation (NASDAQ:OPHT) declined -9.93% yesterday to close its trading session at $30.65. The company has 1 year Price Target of $90.18. Ophthotech Corporation has 52-Week high of $80 and 52-Week Low of $29.85. The stock touched its 52-Week High on Dec 30, 2015 and 52-Week Low on Nov 8, 2016. The stock traded with the volume of 1.65 Million shares yesterday. The firm shows the market capitalization of $1.09 Billion.
Ophthotech Corporation (NASDAQ:OPHT) reported its last quarterly earnings on Sep 16 where the firm reported its Actual EPS of $-1.71/share against the analyst consensus estimate of $-1.64/share. The difference between the actual and expected EPS is $-0.07 a share with a surprise factor of -4.3%.
The firm is trading with SMA20 of -12.49 Percent, SMA50 of -24.37 Percent and SMA200 of -36.66 percent. Ophthotech Corporation has P/S value of 21.71 while its P/B value stands at 0. Similarly, the company has Return on Assets of -41.6 percent, Return on Equity of -916 percent and Return on Investment of -178.2 Percent. The company shows Gross Margin and Operating Margin of 0 percent and 0 percent respectively.
Many brokerage firms are involved in issuing their ratings on Ophthotech Corporation (NASDAQ:OPHT). On 2-Jun-16 JP Morgan Upgrade Ophthotech Corporation Stock to Overweight. Another firm also rated the stock on 27-Apr-16 where Barclays Initiated the stock to Overweight.
The Stock currently has Analyst’ mean Recommendation of 1.8 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 11 analysts offering 12-month price forecasts for Ophthotech Corp have a median target of 92.00, with a high estimate of 200.00 and a low estimate of 22.00. The median estimate represents a +200.16% increase from the last price of 30.65.
Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.
Union Pacific Corporation (NYSE:UNP)
Union Pacific Corp. consists of one reportable segment, rail transportation, and the company’s other product lines. The rail segment includes the operations of the corporation’s wholly owned subsidiary, Union Pacific Railroad Company and Union Pacific Railroad Company’s subsidiaries and rail affiliates. The company’s other operations include the trucking product line, as well as the other product lines that include technology, self-insurance activities, corporate holding company operations, and all appropriate consolidating entries.
Union Pacific Corporation (NYSE:UNP)’s Financial Outlook
The 28 analysts offering 12-month price forecasts for Union Pacific have a median target of 103.50, with a high estimate of 110.00 and a low estimate of 53.00. The median estimate represents a +2.14% increase from the last price of 101.33.
Union Pacific Corporation is estimated to report earnings on 01/19/2017. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 13 analysts’ forecasts, the consensus EPS forecast for the quarter is $1.32. The reported EPS for the same quarter last year was $1.31.
According to Zacks Investment Research, Union Pacific Corporation has a Consensus Recommendation of 2.33. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock gained 0.76% and closed its last trading session at $101.33. The company has the market capitalization of $83.51 Billion. The stock has 52-week high of $102.73 and 52-Week low of $67.06. The firm touched its 52-Week high on Nov 30, 2016 and 52-Week low on Jan 21, 2016. The company has volume of 6.19 Million shares. The company has a total of 824.11 Million shares outstanding.
Union Pacific Corporation (NYSE:UNP) in the last quarter reported its actual EPS of $1.36/share where the analyst estimated EPS was $1.41/share. The difference between the actual and Estimated EPS is $-0.05. This shows a surprise factor of -3.5 percent.
The company has YTD performance of 32.9 percent. Beta for Union Pacific Corporation stands at 0.74 while its ATR (average true range) is 1.72. The company has Weekly Volatility of 1.08%% and Monthly Volatility of 1.92%%.
Union Pacific Corporation has distance from 20-day Simple Moving Average (SMA20) of 5.84%, Distance from 50-Day Simple Moving Average of 7.06 percent and Distance from 200-Day Simple Moving Average of 15.26%.
The Company currently has ROA (Return on Assets) of 7.6 percent, Return on Equity (ROE) of 20.5 Percent and Return on Investment (ROI) of 14.8% with Gross margin of 81.1 percent and Operating & Profit margin of 36.2% and 21% respectively.